Newsfiscal.ai
Acumen Pharmaceuticals to Present Data at 19th Annual Clinical Trials on Alzheimer's Disease Conference
· Published
Article summary
Acumen Pharmaceuticals announced it will present three poster presentations regarding its Phase 2 ALTITUDE-AD trial of sabirnetug at the upcoming 19th Annual Clinical Trials on Alzheimer's Disease (CTAD) conference.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…